Analyst Joon Lee of Truist Financial maintained a Buy rating on Wave Life Sciences (WVE – Research Report), with a price target of ...

JLL said VC investment in the Bay Area’s life sciences and technology research sectors is beginning to rebound, with $35.4 ...

Watertown, Mass., added millions of square feet of lab space in just a few years. Here's how it happened, and why the pace ...

The AIIB was the first such bank to include an oversight mechanism in its founding documents, but it is nearly impossible for people affected to access it. As the West starts to find its feet with ...

The U.S. life sciences development bubble burst at the start of 2024, and it is going to take some time simply to pick up the pieces. There are already signs of recovery for the new year, though.

According to Srini Sriniwasan, managing director of Kotak Alternate Asset Managers, its private equity is probably the largest healthcare investor in the country, having invested around ₹3,000 crore ...

With climbing biotech M&A and IPO activity following the post-pandemic slump, experts offer insights on maximizing value and ...

Last week saw the Chancellor's Autumn Budget, the first for this Government and a Budget that will define their term in ...

4BIO Capital (‘4BIO’) is an international venture capital firm headquartered in London, focused solely on the advanced and emerging therapies sector. The 4BIO team, which has an unrivalled network ...

With the combined expertise and visionary approach of both Esterad Amwaj and SHG, the development is set to redefine ...

Doha: Commercial Bank, a leader in innovative digital banking solutions in Qatar, hosted a ladies exclusive seminar in collaboration with ...

BlackRock and local fund manager Wentworth Capital have acquired two properties in Sydney as seed assets for a $1.5b life ...